Objective-Olive oil polyphenols have shown beneficial properties against cardiovascular risk factors. Their consumption has been associated with higher cholesterol content in high-density lipoproteins (HDL). However, data on polyphenol effects on HDL quality are scarce. We, therefore, assessed whether polyphenol-rich olive oil consumption could enhance the HDL main function, its cholesterol efflux capacity, and some of its quality-related properties, such HDL polyphenol content, size, and composition. Approach and Results-A randomized, crossover, controlled trial with 47 healthy European male volunteers was performed.
O live oil consumption has proven to be protective against the development of cardiovascular pathologies 1 because of its monounsaturated fatty acid content 2 and to other bioactive compounds, such as polyphenols. 3, 4 Previous results from our group showed that olive oil polyphenols increased dose dependently high-density lipoprotein (HDL) cholesterol levels. 3 Although it has been widely reported that low HDL cholesterol levels are strongly associated with high cardiovascular risk, 5 recent data indicate that increased HDL cholesterol levels do not imply a reduction in the risk of experiencing a myocardial infarction. 6 A key objective in cardiovascular disease prevention strategies should, therefore, be not only to increase HDL cholesterol but also to enhance its biological function.
Within this context, our group recently reported that olive oil polyphenols are able to enhance the expression of genes related to HDL metabolism and function. 7 However, no randomized controlled study in humans has been at present performed on the effects of olive oil polyphenols on HDL
Materials and Methods
Materials and Methods are available in the online-only Supplement.
Results

Participants Characteristics
The crossover design of the study is described in Figure 1 . As shown in Table I in the online-only Data Supplement, no significant differences in baseline parameters between our subsample and the whole EUROLIVE study population (The Effect of Olive Oil on Oxidative Damage in European Population; where our volunteers subsample was extracted from) were found. Energy expenditure in leisure time physical activity through the study and dietary patterns remained stable throughout the study. Volunteers' compliance was correct, as reflected in the biomarkers of compliance. 3 Systemic lipid profile did not change after interventions, as described in Table II in the online-only Data Supplement.
In a subsample of 19 volunteers, a favorable but nonsignificant trend toward higher values of HDL particle count was observed after the HPCOO intervention. Raw values of all relevant HDL markers, before and after both interventions, are shown in Table III in the online-only Data Supplement.
Olive Oil Polyphenols Enhance HDL Cholesterol Efflux Capacity
As we see in Figure 2A , the cholesterol efflux capacity from THP-1 macrophages of the participants' HDL fraction was significantly higher after the HPCOO intervention, compared with the low-polyphenol content olive oil one (P=0.043).
Multiple linear regression analyses showed that basal values of cholesterol efflux capacity were significantly related to the HDL particle count. For each increase in 1 μmol/L of baseline HDL particle count values, cholesterol efflux values increased by 0.06 points (P<0.05).
Olive Oil Polyphenols Bind to HDL in a Dose-Dependent Manner
As shown in Figure 2B , the main metabolites of olive oil polyphenols bound to HDL in a dose-dependent manner. This dose-dependent binding was especially relevant for hydroxytyrosol sulfate (P<0.001, when comparing the HPCOO intervention with both baseline and the low-polyphenol content olive oil one).
Increases of olive oil polyphenol metabolites in HDL were associated with enhancements of HDL function. Multiple linear regression analyses revealed that, after the HPCOO intervention, cholesterol efflux capacity values increased significantly with the increment of olive oil polyphenol metabolites in HDL. For each increase in 1 ppb of hydroxytyrosol sulfate in HDL, there was an increase of 15.6% of cholesterol efflux capacity of the volunteers (P<0.05).
Olive Oil Polyphenols Induce the Formation of Larger HDLs
As described in Figure 2C , after the HPCOO intervention, levels of large HDL (HDL 2 ) in plasma increased significantly compared with baseline (P=0.010) or with the low-polyphenol content olive oil one (P=0.050). In parallel, levels of small HDL (HDL 3 ) were significantly lower compared with baseline (P=0.039).
Olive Oil Polyphenols Enhance Some HDL Biophysical Parameters
No changes were observed in HDL cholesterol, triglycerides, phospholipids, and apolipoproteins A1 and A2 after interventions (data not shown). However, olive oil polyphenols induced some changes in biophysical parameters related to the HDL fluidity and core quality ( Table IV in When evaluating the triglyceride content in the HDL core, a significant decrease was observed after the HPCOO intervention compared with baseline (P=0.049), reaching a borderline significance (P=0.057) compared with the low-polyphenol content olive oil intervention. The fluidity of the HDL particle also changed after the consumption of olive oil polyphenols, increasing significantly compared with baseline (P=0.033).
Discussion
Our results show that a 3-week consumption of olive oil polyphenols induced a significant enhancement of the main HDL biological function, its cholesterol efflux capacity. Olive oil polyphenols also induced changes in the biochemical properties of the lipoprotein, which may have contributed to the HDL function enhancement. To our knowledge, this is the first time that first-level evidence about the in vivo health effects of polyphenols on HDL function is reported in healthy volunteers.
The main biological function of the HDL is extracting the excess of cholesterol from the peripheral cells and taking it to the liver to be metabolized and excreted. This cholesterol capture is broadly known as cholesterol efflux, and the main cell types involved in it are the macrophages under the endothelium in blood vessels. 8 This HDL functional property has been broadly tested in several macrophage cell lines and has been inversely related to early atherosclerosis development and to high risk of experiencing a coronary event. 9 In our study, the consumption of olive oil polyphenols enhanced the cholesterol efflux capacity of the volunteers' HDL in a physiological model of THP-1 monocyte-derived macrophages. A similar effect has been described after extravirgin olive oil consumption in a noncontrolled, linear study, 10 after walnuts consumption 11 or a pioglitazone treatment. 9 The HDL cholesterol efflux enhancement after the HPCOO intervention may be promoted by the observed increase in the olive oil polyphenol metabolites bound to the lipoprotein. It has been previously described that an oxidized HDL is more rigid and presents a lower cholesterol efflux capacity. 12 Thus, a better antioxidative protection, conferred by a higher content of olive oil polyphenols in the HDL, may contribute to explain its functional enhancement. The olive oil polyphenol metabolites bound to the HDL after the HPCOO intervention have been shown to have antioxidant properties. 13 Thus, a local antioxidant effect on the HDL is expected. In parallel, in the HPCOO intervention, a less rigid HDL was observed, and an increased HDL fluidity is considered an intermediate marker of enhanced HDL functionality. 12 Considering our evidences, we can hypothesize that the binding of olive oil polyphenols to HDL would increase the fluidity of the particle, thus enhancing the HDL capacity for promoting the cholesterol efflux from cells. Olive oil polyphenols also induced changes in HDL size distribution, which has been closely related to HDL quality. 14 Low levels of large HDL and high levels of small HDL are a pathological trait present in cardiovascular pathologies, as coronary heart disease, 15 although they have not been described as associated with incident coronary events in some prospective studies. 16 Thus, after the HPCOO intervention, large HDL (HDL 2 ) levels were significantly higher, whereas small HDL (HDL 3 ) levels were significantly lower. Our results agree with those reported after an olive oil-rich diet in healthy men 17 or after a Mediterranean diet enriched in nuts. 18 Up to the present, the only HDL functional parameter that has been correlated to incident coronary events is the HDL particle number. 19 Thus, we assessed whether positive changes in this direction happened after the consumption of olive oil polyphenols. Although nonsignificant, we observed a trend toward higher HDL particle count values after the HPCOO intervention. Moreover, a direct relation between baseline values of this parameter and cholesterol efflux capacity has been found in the present work. However, as these results are not conclusive, and because few treatments have been able to induce an enhancement in HDL particle count values, 20 further studies in this line are priority to check this hypothesis. 
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Previous studies demonstrated that high triglyceride levels in the HDL core are present in several cardiovascular pathologies, such as coronary heart disease, 21 and they are related to a less stable conformation of apolipoprotein-A1 in HDL surface (ie, a less stable lipoprotein structure). 22, 23 In our work, significantly lower triglyceride levels in the HDL core were observed. This decrease could be explained by a lower activity of the cholesterol ester transfer protein (CETP). CETP extracts esterified cholesterol from the HDL core to triglyceride-rich lipoproteins, returning triglycerides from triglyceride-rich lipoproteins to HDL. 24 We observed a trend toward a lower CETP activity after HPCOO intervention. This could have happened through a direct blockade of CETP enzyme, as it has been described for apple polyphenols, 25 or through a nutrigenomic inhibition of CETP gene expression, similar to the one reported after a Mediterranean diet consumption. 26 Further studies in this field are required to confirm these hypotheses.
One of the strengths of this study is its crossover design, which permitted the participants to ingest all olive oil types and also reduced possible interferences with confounding variables. As expected, changes after interventions were modest because real-life doses of a single food (which cannot be consumed in high quantities daily) were administered to healthy volunteers. A study limitation was its sample size, responsible for reduced statistical power in some biomarkers with high interindividual variability. It is also possible that an amount of polyphenols, similar to those provided by olive oil, could have come from other food types. A synergistic effect on HDL parameters between polyphenols and other olive oil biological metabolites is as yet unknown.
In conclusion, this is the first time that HDL cholesterol efflux enhancement by polyphenols has been reported in healthy, young population, in a randomized controlled trial. Apart from the enhancement in the main antiatherogenic HDL function, olive oil polyphenols induced a change in HDL size toward larger values. These, together with the enhancement of the stability and the oxidative status of the HDL particle, led to a better HDL functionality after the consumption of olive oil polyphenols. Our data are in line with the previous evidences supporting that the consumption of olive oil polyphenols helps to reduce cardiovascular risk.
